Clinical Trials
3 trialsNCT00438178 2014-05-12
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 1 Completed
NCT00600964 2014-05-12
A Phase I/II Study of GX15-070MS in Untreated CLL
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 1 Completed
NCT00684918 2013-08-26
Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed